Pharmarise Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Pharmarise Holdings has a total shareholder equity of ¥7.1B and total debt of ¥10.4B, which brings its debt-to-equity ratio to 146.8%. Its total assets and total liabilities are ¥27.9B and ¥20.8B respectively. Pharmarise Holdings's EBIT is ¥630.0M making its interest coverage ratio 7.7. It has cash and short-term investments of ¥4.1B.
Key information
146.8%
Debt to equity ratio
JP¥10.39b
Debt
| Interest coverage ratio | 7.7x |
| Cash | JP¥4.10b |
| Equity | JP¥7.08b |
| Total liabilities | JP¥20.78b |
| Total assets | JP¥27.86b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 2796's short term assets (¥12.1B) exceed its short term liabilities (¥10.9B).
Long Term Liabilities: 2796's short term assets (¥12.1B) exceed its long term liabilities (¥9.9B).
Debt to Equity History and Analysis
Debt Level: 2796's net debt to equity ratio (88.9%) is considered high.
Reducing Debt: 2796's debt to equity ratio has reduced from 172% to 146.8% over the past 5 years.
Debt Coverage: 2796's debt is well covered by operating cash flow (26.1%).
Interest Coverage: 2796's interest payments on its debt are well covered by EBIT (7.7x coverage).